Abstract
To evaluate the changes in left ventricular myocardial function in patients with colorectal cancer undergoing chemotherapy with mFOLFOX6 (oxaliplatin + 5-fluorouracil + calcium folinate) using three-dimensional speckle-tracking echocardiography (3D-STE). Data were collected from 30 patients diagnosed with colorectal cancer in our hospital treated with mFOLFOX6. We used 3D-STE to measure the following parameters of left ventricle function: global longitudinal strain (GLS), global area strain (GAS), global circumferential strain (GCS), global radial strain (GRS), and left ventricular twist (LVtw). Myocardial composite index (MCI) was calculated from measured values (MCI = GLS × LVtw). The above listed parameters were compared before and after chemotherapy. Receiver operating curves (ROC) were prepared for each parameter and analyzed to identify correlations among MCI, LVEF, GLS, and cTnT. Compared with the pre-chemotherapy state, the absolute values of MCI, LVtw, GLS, GAS, GCS, and GRS decreased with increasing cumulative doses of chemotherapeutic drugs. The absolute values of GAS, GLS, MCI, and LVtw decreased after the first cycle of chemotherapy (P < 0.05). The areas under the ROC curves for MCI and GLS were 0.903 and 0.838, respectively. The correlation observed between MCI and cTnT (r = − 0.7228) was found to be stronger than that between GLS and cTnT (r = − 0.6008). In conclusion, 3D-STE may help detect early changes in left ventricular myocardial function caused by mFOLFOX6 treatment in patients with colorectal cancer. MCI is a relatively sensitive index among the various measurable parameters.
Graphic abstract
Similar content being viewed by others
References
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet (London, England) 394(10207):1467–1480. https://doi.org/10.1016/s0140-6736(19)32319-0
Wolf AMD, Fontham ETH, Church TR, Flowers CR, Guerra CE, LaMonte SJ, Etzioni R, McKenna MT, Oeffinger KC, Shih YT, Walter LC, Andrews KS, Brawley OW, Brooks D, Fedewa SA, Manassaram-Baptiste D, Siegel RL, Wender RC, Smith RA (2018) Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA: Cancer J Clin 68(4):250–281. https://doi.org/10.3322/caac.21457
Kasi PM, Shahjehan F, Cochuyt JJ, Li Z, Colibaseanu DT, Merchea A (2019) Rising proportion of young individuals with rectal and colon cancer. Clin Colorectal Cancer 18(1):e87–e95. https://doi.org/10.1016/j.clcc.2018.10.002
André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J ClinOncol 27(19):3109–3116. https://doi.org/10.1200/jco.2008.20.6771
Joy G, Eissa H, Al Karoudi R, White SK (2019) Fluorouracil-induced Takotsubo cardiomyopathy causing cardiogenic shock: a case report of clinical and acute cardiac magnetic resonance imaging features. Eur Heart J Case Rep 3(4):1–6. https://doi.org/10.1093/ehjcr/ytz146
Redman JM, Rhea LP, Brofferio A, Whelpley M, Gulley JL, Gatti-Mays ME, McMahon S, Cordes LM, Strauss J (2019) Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion. J GastrointestOncol 10(5):1010–1014. https://doi.org/10.21037/jgo.2019.07.04
Dyhl-Polk A, Vaage-Nilsen M, Schou M, Vistisen KK, Lund CM, Kümler T, Appel JM, Nielsen DL (2020) Incidence and risk markers of 5-fluorouracil and capecitabinecardiotoxicity in patients with colorectal cancer. ActaOncol (Stockholm, Sweden) 59(4):475–483. https://doi.org/10.1080/0284186x.2019.1711164
Polk A, Shahmarvand N, Vistisen K, Vaage-Nilsen M, Larsen FO, Schou M, Nielsen DL (2016) Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer. BMJ Open 6(10):e012798. https://doi.org/10.1136/bmjopen-2016-012798
Labianca R, Beretta G, Clerici M, Fraschini P, Luporini G (1982) Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 68(6):505–510
Meyer CC, Calis KA, Burke LB, Walawander CA, Grasela TH (1997) Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 17(4):729–736
Ray JC, Cho P, Dragon M, Graham CG (2016) A case of 5-fluorouracil-induced cardiac arrest. J Emerg Med 50(1):e1-6. https://doi.org/10.1016/j.jemermed.2015.09.001
McDonald JP, MacNamara JP, Zaha VG (2019) Challenges in implementing optimal echocardiographic screening in cardio-oncology. Curr Treat Options Cardiovasc Med 21(8):39. https://doi.org/10.1007/s11936-019-0740-5
He J, Yang L (2019) Value of three-dimensional speckle-tracking imaging in detecting left ventricular systolic function in patients with dilated cardiomyopathy. Echocardiography (Mount Kisco, NY) 36(8):1492–1495. https://doi.org/10.1111/echo.14427
Reant P, Barbot L, Touche C, Dijos M, Arsac F, Pillois X, Landelle M, Roudaut R, Lafitte S (2012) Evaluation of global left ventricular systolic function using three-dimensional echocardiography speckle-tracking strain parameters. J Am SocEchocardiogr 25(1):68–79. https://doi.org/10.1016/j.echo.2011.10.009
Mornoş C, Petrescu L (2013) Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. Can J PhysiolPharmacol 91(8):601–607. https://doi.org/10.1139/cjpp-2012-0398
Shiga T, Hiraide M (2020) Cardiotoxicities of 5-fluorouracil and other fluoropyrimidines. Curr Treat Options Oncol 21(4):27. https://doi.org/10.1007/s11864-020-0719-1
Südhoff T, Enderle MD, Pahlke M, Petz C, Teschendorf C, Graeven U, Schmiegel W (2004) 5-Fluorouracil induces arterial vasocontractions. Ann Oncol 15(4):661–664. https://doi.org/10.1093/annonc/mdh150
Jensen SA, Sørensen JB (2012) 5-Fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer ChemotherPharmacol 69(1):57–64. https://doi.org/10.1007/s00280-011-1669-x
Polk A, Vaage-Nilsen M, Vistisen K, Nielsen DL (2013) Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev 39(8):974–984. https://doi.org/10.1016/j.ctrv.2013.03.005
Jin X, Bai Y, Gao L, Wu S (2019) Incidence of and risk factors for cardiotoxicity after fluorouracil-based chemotherapy in locally advanced or metastatic gastric cancer patients. Cancer ChemotherPharmacol 84(3):599–607. https://doi.org/10.1007/s00280-019-03888-1
Lestuzzi C, Vaccher E, Talamini R, Lleshi A, Meneguzzo N, Viel E, Scalone S, Tartuferi L, Buonadonna A, Ejiofor L, Schmoll HJ (2014) Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk. Ann Oncol 25(5):1059–1064. https://doi.org/10.1093/annonc/mdu055
Bergamini C, Dolci G, Truong S, Zanolla L, Benfari G, Fiorio E, Rossi A, Ribichini FL (2019) Role of speckle tracking echocardiography in the evaluation of breast cancer patients undergoing chemotherapy: review and meta-analysis of the literature. CardiovascToxicol 19(6):485–492. https://doi.org/10.1007/s12012-019-09523-y
Yanagimoto K, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Kawano Y (2017) Decrease of cardiac base rotation in 2D speckle tracking indicates drug-induced cardiomyopathy after chemotherapy in children with cancer. J PediatrHematolOncol 39(1):10–14. https://doi.org/10.1097/mph.0000000000000683
Muraru D, Niero A, Rodriguez-Zanella H, Cherata D, Badano L (2018) Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging. CardiovascDiagnTher 8(1):101–117. https://doi.org/10.21037/cdt.2017.06.01
Coutinho Cruz M, MouraBranco L, Portugal G, Galrinho A, Timóteo AT, Rio P, Ilhão Moreira R, Mendonça T, Leal A, Gameiro F, Duarte Oliveira S, Luz R, Cruz Ferreira R (2020) Three-dimensional speckle-tracking echocardiography for the global and regional assessments of left ventricle myocardial deformation in breast cancer patients treated with anthracyclines. Clin Res Cardiol 109(6):673–684. https://doi.org/10.1007/s00392-019-01556-1
Chen J, Wang L, Wu FF, Sun G (2019) Early detection of cardiotoxicity by 3D speckle tracking imaging of area strain in breast cancer patients receiving chemotherapy. Echocardiography (Mount Kisco, NY) 36(9):1682–1688. https://doi.org/10.1111/echo.14467
Potter E, Marwick TH (2018) Assessment of left ventricular function by echocardiography: the case for routinely adding global longitudinal strain to ejection fraction. JACC Cardiovasc Imaging 11(2 Pt 1):260–274. https://doi.org/10.1016/j.jcmg.2017.11.017
Ong G, Yan AT, Connelly KA (2019) Clinical application of echocardiographic-derived myocardial strain imaging in subclinical disease: a primer for cardiologists. CurrOpinCardiol 34(2):147–155. https://doi.org/10.1097/hco.0000000000000592
Neilan TG, Jassal DS, Perez-Sanz TM, Raher MJ, Pradhan AD, Buys ES, Ichinose F, Bayne DB, Halpern EF, Weyman AE, Derumeaux G, Bloch KD, Picard MH, Scherrer-Crosbie M (2006) Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury. Eur Heart J 27(15):1868–1875. https://doi.org/10.1093/eurheartj/ehl013
Kosmas C, Kallistratos MS, Kopterides P, Syrios J, Skopelitis H, Mylonakis N, Karabelis A, Tsavaris N (2008) Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study. J Cancer Res ClinOncol 134(1):75–82. https://doi.org/10.1007/s00432-007-0250-9
Chong JH, Ghosh AK (2019) Coronary artery vasospasm induced by 5-fluorouracil: proposed mechanisms, existing management options and future directions. IntervCardiol (London, England) 14(2):89–94. https://doi.org/10.15420/icr.2019.12
Kim SM, Kwak CH, Lee B, Kim SB, Sir JJ, Cho WH, Choi SK (2012) A case of severe coronary spasm associated with 5-fluorouracil chemotherapy. Korean J Intern Med 27(3):342–345. https://doi.org/10.3904/kjim.2012.27.3.342
Buckberg G, Hoffman JI, Mahajan A, Saleh S, Coghlan C (2008) Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation 118(24):2571–2587. https://doi.org/10.1161/circulationaha.107.754424
Seo Y, Ishizu T, Enomoto Y, Sugimori H, Aonuma K (2011) Endocardial surface area tracking for assessment of regional LV wall deformation with 3D speckle tracking imaging. JACC Cardiovasc Imaging 4(4):358–365. https://doi.org/10.1016/j.jcmg.2010.12.007
Li SN, Wong SJ, Cheung YF (2011) Novel area strain based on three-dimensional wall motion analysis for assessment of global left ventricular performance after repair of tetralogy of Fallot. J Am SocEchocardiogr 24(8):819–825. https://doi.org/10.1016/j.echo.2011.03.020
Sengupta PP, Krishnamoorthy VK, Korinek J, Narula J, Vannan MA, Lester SJ, Tajik JA, Seward JB, Khandheria BK, Belohlavek M (2007) Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J Am SocEchocardiogr 20(5):539–551. https://doi.org/10.1016/j.echo.2006.10.013
Pokharel P, Yoon AJ, Bella JN (2014) Noninvasive measurement and clinical relevance of myocardial twist and torsion. Expert Rev CardiovascTher 12(11):1305–1315. https://doi.org/10.1586/14779072.2014.970179
Mehta L, Watson K, Barac A, Beckie T, Bittner V, Cruz-Flores S, Dent S, Kondapalli L, Ky B, Okwuosa T, Piña I, Volgman A (2018) Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation 137(8):e30–e66
Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, Kaluski E, Krakover R, Vered Z (2004) Two-dimensional strain—a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17(10):1021–1029. https://doi.org/10.1016/j.echo.2004.06.019
Acknowledgements
The authors would like to thank the National Natural Science Foundation of China (81460075) for their support in this research. The authors would like to thank the Hospital-level project of First Affiliated Hospital of Medical College, Shihezi University (QN201901; QN201919; QN202019).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study has passed an ethical review and the aapproval number is 2019-124-01. The study has been approved for clinical trial registration with the registration number chiCTR2000035226, and the registration date of 2020.08.04.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wang, Z., Qin, W., Zhai, Z. et al. Use of spectral tracking technique to evaluate the changes in left ventricular function in patients undergoing chemotherapy for colorectal cancer. Int J Cardiovasc Imaging 37, 1203–1213 (2021). https://doi.org/10.1007/s10554-020-02103-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-020-02103-0